In a bold move to support the Hatch-Waxman Act related to the operation of pharmaceutical companies, the FDA has announced a new website. The proposed site hosts the names of branded medicine manufacturers blocking generic versions of their medicines. This move, announced by FDA Commissioner Scott Gottlieb, seems to be directly aimed at... Read more